CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $22,875 | -36.2% | 15,668 | 0.0% | 0.00% | – |
Q2 2023 | $35,880 | +28.1% | 15,668 | +39.7% | 0.00% | – |
Q4 2021 | $28,000 | -49.1% | 11,217 | 0.0% | 0.00% | – |
Q3 2021 | $55,000 | +27.9% | 11,217 | -18.9% | 0.00% | – |
Q1 2021 | $43,000 | -70.5% | 13,830 | -61.9% | 0.00% | – |
Q1 2019 | $146,000 | +52.1% | 36,275 | +40.1% | 0.00% | – |
Q4 2018 | $96,000 | -57.0% | 25,900 | 0.0% | 0.00% | – |
Q3 2018 | $223,000 | -21.8% | 25,900 | 0.0% | 0.00% | – |
Q2 2018 | $285,000 | +41.1% | 25,900 | +48.0% | 0.00% | – |
Q1 2018 | $202,000 | +11.0% | 17,500 | 0.0% | 0.00% | – |
Q4 2017 | $182,000 | -34.8% | 17,500 | 0.0% | 0.00% | – |
Q3 2017 | $279,000 | +31.6% | 17,500 | 0.0% | 0.00% | – |
Q2 2017 | $212,000 | – | 17,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ADAMS STREET PARTNERS LLC | 3,275,616 | $2,784,274 | 0.93% |
CHI Advisors LLC | 2,384,402 | $2,026,742 | 0.54% |
Telemetry Investments, L.L.C. | 390,000 | $332 | 0.52% |
Orbimed Advisors | 6,943,654 | $5,902,106 | 0.11% |
DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 548,727 | $466,418 | 0.07% |
BVF INC/IL | 1,370,947 | $1,165,305 | 0.05% |
JACKSON SQUARE CAPITAL, LLC | 63,773 | $54,207 | 0.03% |
Artal Group S.A. | 500,000 | $425 | 0.02% |
Hikari Power Ltd | 49,959 | $42 | 0.00% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 159,300 | $135,405 | 0.00% |